DarioHealth Corp. (DRIO)
NASDAQ (CM) NASDAQ (CM) Primary 
DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Chen Franco-Yehuda - CFO, Treasurer & Secretary Erez Raphael - CEO & Director Steven C. Nelson - President & Chief Commercial Officer Zoe Harrison - Corporate Participant Conference Call Participants Theodore Rudd O'Neill - Litchfield Hills Research, LLC Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Second Quarter 2025 Results Conference Call.
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dodo - Acting Chief Operating Officer Conference Call Participants Charles Yi - TD Securities David Grossman - Stifel Nicolaus Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth First Quarter 2025 Results Conference Call. At this time, all lines are in a listen-only mode.
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.20 per share a year ago.
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know
DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter 2024 Results Conference Call. At this time, all lines are in listen-only mode.
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2024 Results Call. [Operator Instructions] This call is being recorded on November 7, 2024.
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.49 per share a year ago.
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
DarioHealth (DRIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Adverum Biotechnologies (ADVM), IceCure Medical (ICCM), DarioHealth (DRIO), Energous (WATT) and Virgin Galactic (SPCE).
DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q2 2024 Results Conference Call August 8, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Lucas Romanski - TD Cowen Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Second Quarter 2024 Results Conference Call. At this time, all lines are in a listen-only mode.
DarioHealth Corp. (DRIO) Q2 Earnings Beat Estimates
DarioHealth Corp. (DRIO) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.29 per share. This compares to loss of $0.58 per share a year ago.
